Sarah McCague
- Ophthalmology top 2%
- Retinal Diseases and Treatments 5
- Retinal and Optic Conditions 1
-
- Retinal Development and Disorders 7
- CRISPR and Genetic Engineering 1
- RNA regulation and disease 1
- Genetics top 10%
- Virus-based gene therapy research 2
-
- Cerebral Palsy and Movement Disorders 2
-
- Neurological diseases and metabolism 1
- Co-authors
- Katherine A. HighKathleen MarshallJean BennettJennifer WellmanDaniel C. ChungFrancesca SimonelliJ. Fraser WrightAlbert M. Maguire
- Journals
- Ophthalmology (1 paper)Science Translational Medicine (1 paper)Investigative Ophthalmology & Visual Science (4 papers)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Sarah McCague
7 papers receiving 690 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Ophthalmology 291
- Molecular Biology 628
- Genetics 242
- Cellular and Molecular Neuroscience 112
- Radiology, Nuclear Medicine and Imaging 105
Countries citing papers authored by Sarah McCague
This map shows the geographic impact of Sarah McCague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah McCague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah McCague more than expected).
Fields of papers citing papers by Sarah McCague
This network shows the impact of papers produced by Sarah McCague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah McCague. The network helps show where Sarah McCague may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah McCague, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: 2 year Results of an Ongoing Phase I/II Gene Therapy Trial | 2019 | 5 |
| 3 | Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophybreakdown → | 2019 | 276 |
| 4 | AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I/II Gene Therapy Trial | 2017 | 4 |
| 5 | Natural History of Individuals with Retinal Degeneration Due to Biallelic Mutations in the RPE65 Gene | 2017 | 2 |
| 6 | 2017 | 105 | |
| 7 | The Natural History of Disease Progression in Patients With RPE65-Mediated Inherited Retinal Dystrophies | 2016 | 0 |
| 8 | Mobility testing validation study - Using a novel, standardized mobility test to evaluate functional vision in patients with inherited retinal degeneration | 2015 | 1 |
| 9 | 2012 | 309 |
About Sarah McCague
Sarah McCague is a scholar working on Ophthalmology, Psychiatry and Mental health and Neurology, having authored 9 papers that have together received 702 indexed citations. Recurring topics across this work include Retinal Development and Disorders (7 papers), Retinal Diseases and Treatments (5 papers), Virus-based gene therapy research (2 papers), Cerebral Palsy and Movement Disorders (2 papers), Retinal and Optic Conditions (1 paper), Neurological diseases and metabolism (1 paper), CRISPR and Genetic Engineering (1 paper) and RNA regulation and disease (1 paper). The work is most often cited by research in Ophthalmology (291 citations), Molecular Biology (628 citations) and Genetics (242 citations). Sarah McCague has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Katherine A. High, Kathleen Marshall, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Francesca Simonelli, J. Fraser Wright, Albert M. Maguire, Zi‐Fan Yu and Okan U. Elci. Their work appears in journals such as Ophthalmology, Science Translational Medicine and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.